BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 28, 2021, titled "BALAXI commits to backward integration for manufacturing new market-specific differentiated formulations that will serve to expand its portfolio of newly developed, proprietary, and niche branded formulations".